Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors

被引：1
|
作者：
Roschewski, Mark [1 ]
Dunleavy, Kieron [1 ]
机构：
[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 06期
关键词：
OCCULT LEPTOMENINGEAL DISEASE; NON-HODGKINS-LYMPHOMA; DOUBLE-HIT LYMPHOMA; RISK-FACTORS; ELDERLY-PATIENTS; RITUXIMAB; RELAPSE; INVOLVEMENT; PROPHYLAXIS; RECURRENCE;
D O I：
10.3109/10428194.2015.1016936
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1583 / 1584
页数：2
相关论文
共 50 条
  • [31] Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis
    Liu, Xiaobei
    Mo, Fei
    Zeng, Hao
    Zhu, Sha
    Ma, Xuelei
    BIOMEDICAL REPORTS, 2019, 11 (02) : 70 - 78
  • [32] Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma
    Mannisto, S.
    Vahamurto, P.
    Pollari, M.
    Clausen, M. R.
    Jyrkkio, S.
    Kellokumpu-Lehtinen, P. -L.
    Kovanen, P.
    Karjalainen-Lindsberg, M. -L.
    d'Amore, F.
    Leppa, S.
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 27 - 36
  • [33] New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
    Cai, Qing-Qing
    Hu, Li-Yang
    Geng, Qi-Rong
    Chen, Jie
    Lu, Zhen-Hai
    Rao, Hui-Lan
    Liu, Qing
    Jiang, Wen-Qi
    Huang, Hui-Qiang
    Lin, Tong-Yu
    Xia, Zhong-Jun
    CHINESE JOURNAL OF CANCER, 2016, 35 : 87
  • [34] Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy
    Maciocia, Paul
    Badat, Mohsin
    Cheesman, Simon
    D'Sa, Shirley
    Joshi, Rahul
    Lambert, Jonathan
    Mohamedbhai, Sajir
    Pule, Martin
    Linch, David
    Ardeshna, Kirit
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (04) : 545 - 553
  • [35] Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma
    Chua, Bernard Ji Guang
    Low, Chen Ee
    Yau, Chun En
    Tan, Ya Hwee
    Chiang, Jianbang
    Chang, Esther Wei Yin
    Chan, Jason Yongsheng
    Poon, Eileen Yi Ling
    Somasundaram, Nagavalli
    Rashid, Mohamed Farid Bin Harunal
    Tao, Miriam
    Lim, Soon Thye
    Yang, Valerie Shiwen
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [36] Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
    Roschewski, Mark
    Hodson, Daniel J.
    HAEMATOLOGICA, 2024, 109 (02) : 388 - 400
  • [37] Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma
    Kansara, Roopesh
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (11)
  • [38] Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
    Tai, W. M.
    Chung, J.
    Tang, P. L.
    Koo, Y. X.
    Hou, X.
    Tay, K. W.
    Quek, R.
    Tao, M.
    Lim, S. T.
    ANNALS OF HEMATOLOGY, 2011, 90 (07) : 809 - 818
  • [39] Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma
    Fox, Christopher P.
    Phillips, Elizabeth H.
    Smith, Jeffery
    Linton, Kim
    Gallop-Evans, Eve
    Hemmaway, Claire
    Auer, Dorothee P.
    Fuller, Charlotte
    Davies, Andrew J.
    McKay, Pamela
    Cwynarski, Kate
    Jones, Gail
    Pratt, Guy
    Stern, Simon
    Lambert, Jonathan
    Parry-Jones, Nilima
    McKay, Pam
    Whiteway, Alastair
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (03) : 348 - 363
  • [40] Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
    Villa, D.
    Connors, J. M.
    Shenkier, T. N.
    Gascoyne, R. D.
    Sehn, L. H.
    Savage, K. J.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1046 - 1052
12345